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Eukaryotic endocytosis involves multivesicular bodies formation, which is driven by endosomal sorting complexes required for
transport (ESCRT). Here, we showed the presence and expression of homologous ESCRT genes in Entamoeba histolytica.W e
c l o n e da n de x p r e s s e dt h eEhvps4 gene, an ESCRT member, to obtain the recombinant EhVps4 and generate speciﬁc antibodies,
which immunodetected EhVps4 in cytoplasm of trophozoites. Bioinformatics and biochemical studies evidenced that rEhVps4 is
an ATPase, whose activity depends on the conserved E211 residue. Next, we generated trophozoites overexpressing EhVps4 and
mutant EhVps4-E211Q FLAG-tagged proteins. The EhVps4-FLAG was located in cytosol and at plasma membrane, whereas the
EhVps4-E211Q-FLAG was detected as abundant cytoplasmic dots in trophozoites. Erythrophagocytosis, cytopathic activity, and
hepatic damage in hamsters were not improved in trophozoites overexpressing EhVps4-FLAG. In contrast, EhVps4-E211Q-FLAG
protein overexpression impaired these properties. The localization of EhVps4-FLAG around ingested erythrocytes, together with
our previous results, strengthens the role for EhVps4 in E. histolytica phagocytosis and virulence.
1.Introduction
Entamoeba histolytica is the enteric protozoan parasite
responsible for human amoebiasis that aﬀects 50 million
people around the world, causing colitis and liver abscesses
[1]. In this organism, phagocytosis and vesicular traﬃcking
play a critical role in ingestion and degradation of host cells
and microorganisms. Vacuolar protein sorting (Vps) factors
and some proteins that participate in vesicle transport in
eukaryotes have been identiﬁed in E. histolytica [2–4].
In eukaryotic cells, endocytosis consists in phagocytosis,
micropinocytosis and pinocytosis. Particularly, phagocytosis
involves the ingestion of particles of varying size into
phagosomes, which sequentially fuse with early and late
endosomes forming multivesicular bodies (MVB), as well as
with lysosomes to form phagolysosomes [5]. Additionally,
MVB are critical for cell receptors down-regulation, retro-
viral budding and other processes [6–8]. MVB formation
is driven by the assembly of endosomal sorting complexes
required for transport (ESCRT), which result from the
interaction of diﬀerent class E Vps proteins [9, 10].
The MVB-sorting process initiates with the association
of Vps27 and Hse1 proteins to form the ESCRT-0 complex,
which is targeted to endosomal membrane domains that
bind ubiquitinated cargo proteins (reviewed in [6, 7]). Then,
ESCRT-0 recruits ESCRT-I formed by Vps23, Vps28, and2 Journal of Biomedicine and Biotechnology
Vps37 proteins, as well as an additional subunit called
Mvb12 [11, 12]. Later, ESCRT-II, composed by Vps22,
Vps25, and Vps36 proteins, is activated by ESCRT-I [13].
Ubiquitinated cargo proteins are recognized by ESCRT-I
via Vps23 and by ESCRT-II via Vps36. Then, ESCRT-III,
formed by Vps20, Vps32, Vps2, and Vps24, interacts with
ESCRT-II components to complete ESCRT formation [14].
ESCRT-III is required for cargo molecules concentration
into MVB vesicles and it coordinates the association of Bro1
protein and Doa4-deubiquitinating enzyme [15–17]. Finally,
Vps4 protein catalyzes the ATP-dependent dissociation of
ESCRT complexes from endosomes to initiate new rounds
of vesicle formation and cargo molecules transport [6, 7].
Particularly, it has been reported that substitution of the
conserved E amino acid residue by a Q residue in the
Vps4 ATPase motif impairs ATP hydrolysis activity [18, 19],
resulting in an ineﬃc i e n tp r o t e i nt r a n s p o r tf r o me n d o s o m a l
compartments to vacuoles or lysosomes [20–22], which
evidenced the critical role of Vps4 in protein transport and
vesicle traﬃcking.
In E. histolytica, experimental evidence suggests that
MVB-like structuresare formed by fusion of inwardbudding
membranes with phagosomes [23]. Ubiquitin, deubiquiti-
nating enzymesand aSNF7 homologue(vesiculartraﬃcking
protein) have been identiﬁed in isolated phagosomes by
proteomic analysis, suggesting that a mechanism similar
to MVB formation could be present in E. histolytica [23–
25]. Additionally, the Bro1 domain-containing EhADH112
protein, which forms part of the E. histolytica EhCPADH
complex involved in parasite virulence, is located in MVB-
like structures in trophozoites [26, 27]. However, molecular
mechanisms regulating MVB formation in E. histolytica
remain poorly understood. Here, by in silico analysis from
parasite genome databases, we identiﬁed 20 ESCRT protein-
encoding genes in E. histolytica and showed that most of
them were transcribed in trophozoites. Since Vps4 has been
described as a key molecule to complete the disassembly
of ESCRT and associated factors in other systems, we
initiated the study of ESCRT machinery in E. histolytica by
cloning and characterizing the EhVps4 protein. Biochemical
assays showed that EhVps4 exhibits ATPase activity in vitro.
Interestingly, by using trophozoites overexpressing the wild
type and a mutant version of EhVps4, we provide data
supporting a role for this protein in phagocytosis and
virulence.
2.MaterialandMethods
2.1. In Silico Identiﬁcation of Putative ESCRT Genes in E.
histolytica. Sequence similarity searches for ESCRT genes
were performed in E. histolytica genome database (http://
pathema.jcvi.org/cgi-bin/Entamoeba/PathemaHomePage
.cgi) by BLAST using human and yeast ESCRT protein
sequences as queries. Putative E. histolytica ESCRT
homologous proteins were selected using the following
criteria: (i) at least 20% identity and 35% similarity to
the query sequence; (ii) e-value lower than 0.002; and (iii)
absence of stop codons in the coding sequence. Predicted
amino acids sequences were aligned by ClustalW software
(http://www.ebi.ac.uk/clustalw/). Functional and structural
domains were predicted using PROSITE (http://www.expasy
.org/tools/scanPROSITE/) and Pfam (http://www.sanger.ac
.uk/Software/Pfam/) databases. Phylo-genetic relationships
among putative ESCRT proteins from E. histolytica and
other organisms were analyzed using the Neighbor-Joining
distance method [28] as implemented in the MEGA package
version 3.1 [29]. Phylogenetic trees were generated for
each putative E. histolytica ESCRT protein aligned with
homologues from diﬀerent species. Robustness of phyloge-
netic inferences was tested by bootstrapping method,
involving 1000 replications of the data based on the criteria
of 50% majority-rule consensus.
For3DmodelingofMITandAAAdomainsofE.histolyt-
ica EhVps4, predicted tertiary structures were obtained with
the Phyre server (http://www.sbg.bio.ic.ac.uk/phyre/), using
crystal data from yeast Vps4 MIT (2v6xA) and AAA (2qpaB)
domains as templates.
2.2. E. histolytica Cultures. Trophozoites of E. histolytica
clone A (strain HM1: IMSS) were axenically cultured in
TYI-S-33 medium at 37◦C and harvested during exponential
growth phase [30]. Medium for transfected trophozoites was
supplemented with 40μg/mL G418 (Gibco). Cell viability
was monitored by microscopy using Trypan blue dye exclu-
sion test.
2.3. Semi-Quantitative RT-PCR Assays. Using Trizol reagent
(Invitrogen), total RNA was extracted from 106 trophozoites
growninTYI-S-33mediumor5minutesafterredbloodcells
(RBC) ingestion. Semiquantitave RT-PCR was performed
using 1μg of DNAse I-treated total RNA that was reverse
transcribed using Superscript II (Invitrogen) for 2 hours at
42◦C. Control samples without Superscript-II were included
in all experiments. cDNA samples were subjected to PCR
ampliﬁcation using speciﬁc internal primers for distinct E.
histolyticaputative ESCRT genes(see TableT1 in Supplemen-
tary material available on line at doi: 10.1155/2010/890674).
Brieﬂy, PCR consisted in an initial denaturation step at 94
◦C
for 5 minutes followed by 25 cycles of 35s at 94
◦C, 30s
at Tm calculated for each gene (Supplementary data Table
T1), 1 minute 30s at 72
◦C and a ﬁnal extension step at
72
◦C for 7 minutes. As a control, we ampliﬁed a Eh25S
rRNA gene internal sequence which was used to normalize
densitometric data. Products were separated by 1% agarose
gel electrophoresis, stained with ethidium bromide and
visualizedbyUVlightinaGelDoc1000apparatus(BioRad).
Densitometric analysis was performed using the Quantity
One software. Three independent experiments were done
by duplicate. Statistical signiﬁcance was determined by T
Student test [31].
2.4. Cloning and Sequencing of Ehvps4 and Ehvps4-E211Q
Genes. The full-length Ehvps4 gene (1260bp) reported at
locus EHI 118900 in E. histolytica Pathema database was
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Ehvps4-forward (5 -CCCCCGGATCCATGACATCGTTAC-
TTGATAAAGG-3 )a n dEhvps4-reverse (5 -CCCCCCTCG-
AGTTATCCATCTTGTCCAAATTGTTC-3 ) primers in the
presence of 0.2U Pfx DNA polymerase (Invitrogen). Brieﬂy,
PCR consisted in an initial denaturation step at 94
◦Cf o r5
minutes followed by 28 cycles (30s at 94
◦C, 35 s at 55
◦C, and
1m i n u t e3 0sa t7 2
◦C) and a ﬁnal extension step at 72
◦Cf o r
7 minutes. The PCR product was cloned into TOPO vector
(Invitrogen) yielding the TOPO-Ehvps4 plasmid. Using the
QuikChange mutagenesis kit (Stratagene), we generated a
point mutation in the EhVps4 ATPase domain at amino acid
211 to replace glutamic acid (E) by glutamine (Q) to obtain
the TOPO Ehvps4-E211Q plasmid. Both constructions were
conﬁrmed by automated DNA sequencing. Then, Ehvps4
and Ehvps4-E211Q genes were PCR ampliﬁed from TOPO
plasmids and subcloned in the pGEX-6P1 expression vector
(AmershamBiosciences)togeneratetherecombinantpGEX-
6P1-Ehvps4 and pGEX-6P1-Ehvps4-E211Q plasmids, respec-
tively. Constructions were conﬁrmed by automated DNA
sequencing.
2.5. Expression and Puriﬁcation of Recombinant EhVps4-
GST and EhVps4-E211Q-GST Proteins. Escherichia coli BL21
(DE3) pLysS (Invitrogen) bacteria were transformed with
pGEX-6P1-Ehvps4 or pGEX-6P1-Ehvps4-E211Q plasmids
to produce the GST-tagged rEhVps4 and rEhVps4E211Q
proteins. Bacteria were grown at 37
◦C in 2-TY medium
containing 100μg/mL ampicillin and 34μg/mL chloram-
phenicol. rEhVps4-GST expression was induced by 1mM
isopropyl beta-D-thiogalacto pyranoside (IPTG) for 3 hours
at 37
◦C. Cells were harvested, resuspended in ice cold PBS
buﬀer (140mM NaCl, 2.7mM KCl, 10mM Na2HPO4,a n d
1.8mM KH2PO4 pH 7.3) and lysed by sonication at 4◦C
in the presence of lisozyme (1mg/mL). rEhVps4-GST and
rEhVps4-E211Q-GST polypeptides were puriﬁed near to
homogeneity through glutathione aﬃnity chromatography,
according to manufacturer recommendations (Amersham
Biosciences). To further use the recombinant protein as
antigen, the GST tag (25kDa) was removed from rEhVps4-
GST protein by incubation with 2U PreScission Protease
(Amersham Biosciences) during 12 hours at 4◦C. Cleaved
rEhVps4 protein was dialyzed into PBS pH 7.4. Identity and
integrity of puriﬁed rEhVps4-GST, rEhVps4-E211Q-GST
and rEhVps4 proteins were conﬁrmed by 10% SDS-PAGE
and Western blot assays using anti-GST, (GE-Healthcare,
1 : 5000 dilution) and anti-rEhVps4 (1 : 15000 dilution)
antibodies, respectively, and the ECL-Plus Western blotting
detection system (Amersham Biosciences).
2.6. Generation of Polyclonal Antibodies against EhVps4.
Puriﬁed rEhVps4 without GST tag was submitted to prepar-
ative 10% SDS-PAGE and electroeluted from Coomassie
stained gels. rEhVps4 (200μg) in complete Freund’s adju-
vant (Sigma) was subcutaneously inoculated into a New
Zealand male rabbit, and then, three doses of 100μg
rEhVps4 in incomplete Freund’s adjuvant were injected at
15 days intervals. Rabbit was bled to obtain polyclonal
serum.
2.7. ATPase Activity Assay. T h eA T P a s ea c t i v i t ya s s a yp r o -
cedure was based on that previously described [32] using
the PiPer Phosphate Assay kit (Invitrogen), with minimal
modiﬁcations. Brieﬂy, Amplex red was diluted in DMSO
to a 10mM ﬁnal concentration. Maltose phosphorylase,
maltose, glucose oxidase, and horseradish peroxidase were
diluted in enzyme buﬀer (0.1M Tris-HCl, pH 7.5) to a
ﬁnal concentration of 200U/mL, 40mM, 200U/mL, and
100U/mL, respectively. Assay buﬀer (100mM Tris, 20mM
KCl, and 6 mM MgCl2, pH 7.4) was added to a 96-well plate.
The volume corresponding to 3.5μga n d5 μgo fp u r i ﬁ e d
anddialyzedrEhVps4-GST,rEhVps4-E211Q-GST, andrGST
proteins was added to wells and enzyme buﬀer was added up
to 27μL. 50μL of working solution (2U/mL glucose oxidase,
4U/mL maltose phosphorylase, 0.4mM maltose, 100μM
amplex red, 0.4U/mL HRP) were added to wells. Controls
consisting in enzyme buﬀer or enzyme buﬀer with working
solution were included. Fresh ATP was diluted in assay buﬀer
to a concentration of 2.5mM and added to each well to a
ﬁnal volume of 100μL. Plates were mixed by pipetting and
shackedfor30stoensurehomogeneity.Then,reactionswere
kept at 25
◦C for 30 minutes and protected from the light.
The absorbance was measured at 562nm at 30 minutes and
data were documented. The puriﬁed rGST protein was used
as negative control in ATPase assays. Assays were performed
twice by triplicate.
2.8. Plasmids Construction for Transfection Assays. The
mutant Ehvps4-E211Q gene and the wild type Ehvps4
gene were PCR ampliﬁed from TOPO Ehvps4-E211Q and
TOPO-Ehvps4, respectively, using the Ehvps4-S-KpnI( 5  -
CCCCCGGTACCATGACATCGTTACTTGATAAAGG-3 )
and Ehvps4-AS-FLAG-BamHI (5 -CCCCCGGATCCT-
TACTTATCGTCGTCATCCTTGTAATCTCCATCTTGTCC-
AAATTGTTC-3 ) primers and cloned into pNEO vector for
further transfection assays [33]. The underlined nucleotide
sequence corresponds to the FLAG epitope (1kDa) [34] that
was added to the carboxy terminus of recombinant proteins
to allow their speciﬁc immunodetection in transfected
trophozoites. The resulting plasmids named pEhVps4-
E211Q and pEhVps4 were conﬁrmed by automated DNA
sequencing.
2.9. In Vitro and In Vivo Virulence of Transfected Cells.
Trophozoites were transfected with 200μgo fp EhVps4-
E211Q, pEhVps4 and control pNEO plasmids by electro-
poration as described [33]. Brieﬂy, amoebae (107)w e r e
washed twice in cold PBS and once in cold complete cytomix
buﬀer. Electroporation was performed with the Bio-Rad
GenePulserusing 1200V/cmand25μF,witha constanttime
of 0.4ms. Electroporated cells were transferred into fresh
culture medium for 48 hours before selecting them with
10μg/mL G418.
In vitro virulence of nontransfected and transfected
trophozoites (105) was measured on MDCK cells (6 ×
104)a sd e s c r i b e d[ 35, 36]. Rate of erythrophagocytosis was
evaluated using trophozoites and RBC in a 1 : 100 relation,
at 5, 10, and 15 minutes [37].4 Journal of Biomedicine and Biotechnology
In vivo virulence of transfected trophozoites was evalu-
ated as described [38]. Brieﬂy, under sterile conditions and
intraperitoneal anaesthesia with 0.2mg Anesthesal (Pﬁzer),
three groups of six hamsters each were laparotomized and
intraportally challenged with pEhVps4-E211Q, pEhVps4, or
pNEO transfected trophozoites (2.5 × 106)i nav o l u m eo f
0.1mL PBS using a 29-gauge needle. Seven days after chal-
lenge, animals were anaesthetized and livers were removed to
evaluate hepatic damage.
2.10. Immunodetection of EhVps4 in Trophozoites. Western
blot assays were performed using 30μg of total proteins
from nontransfected or pNEO,p EhVps4,a n dp EhVps4-
E211Q transfected trophozoites. We used anti-FLAG mon-
oclonal (1 : 700) or anti-rEhVps4 polyclonal (1 : 15000)
antibodies and rabbit anti-mouse and goat anti-rabbit
IgG horseradish peroxidase-labeled secondary antibodies
(Zymed; 1 : 10000), respectively. Immunodetected proteins
were revealed with the ECL Plus Western blotting system
(Amersham Biosciences). As an internal control, we used
monoclonal antibodies raised against E. histolytica actin
(1 : 1000) and goat anti-mouse IgG horseradish peroxidase-
labeled secondary antibodies (Zymed; 1 : 10000).
For confocal microscopy assays, nontransfected and
transfectedtrophozoitesweregrownoncoverslips,ﬁxedwith
4% paraformaldehyde at 37◦C for 1 hour, permeabilized
with Triton X-100 and blocked with 1% bovine serum
albumin in PBS. Then, nontransfected and transfected cells
were incubated with polyclonal anti-rEhVps4 (1 : 5000) or
monoclonal anti-FLAG primary antibodies (Sigma; 1 : 500),
respectively, at 37◦C for 2 hours, followed by incubation
with anti-rabbit or anti-mouse ﬂuoresceinated (Zymed;
1 : 100) monoclonal antibodies, at 37◦Cf o r1h o u r .N e x t ,
trophozoites were washed three times with PBS 1X at
room temperature and DNA was counterstained with 4 ,
6-diamidino-2-phenylindole (DAPI) (5μg/mL) for 5 min-
utes. To immunolocalize EhVps4 during erytrophagocytosis,
pEhVps4 transfected cells were incubated with RBC (1 : 20)
for10minutes.IngestedRBCwerestainedwithdiaminoben-
zidine (0.84mM 3,3 -diaminobenzidine, 0.048% H2O2 and
50mM Tris-HCl, pH 9.5) for 5 minutes and cells were
incubated with polyclonal anti-rEhVps4 (1 : 5000) to be
processed for immunoﬂuorescence as described above. Light
optical sections (1.5μm) were obtained through a Leica
inverted microscope attached to a laser confocal scanning
system TCS-SP2 (Leica).
3. Results
3.1. E. histolytica Genome Contains Homologous ESCRT
G e n e sT h a tA r eE x p r e s s e di nT r o p h o z o i t e s .To investigate
the presence of ESCRT-related genes in E. histolytica,w e
surveyed the parasite genome sequence at Pathema database
using the amino acid sequences of yeast and human ESCRT
proteins as queries. We detected a set of 20 putative
ESCRT protein-encoding genes, which exhibited signiﬁcant
e-values (1.1e − 114 to 0.00032) and high similarity (20
to 62%) to yeast and human ESCRT (ESCRT 0-III and
associated factors) orthologues (see Table 1). However, we
did not ﬁnd homologues for yeast Mvb12, and Bul1p protein
involved in protein ubiquitination, neither human Vps37-
B and Vps37-C proteins. Phylogenetic inference revealed
that E. histolytica ESCRT predicted proteins are closely
related to homologous proteins from other protozoa, such
as Giardia lamblia, Tetrahymena thermophila, Trichomonas
vaginalis, Plasmodium vivax, Cryptosporidium homini, and
Trypanosomacruzi(datanotshown).Bioinformaticsanalysis
showed that E. histolytica ESCRT predicted proteins have the
most characteristic functional domains (see Supplementary
data Figure S1) and tertiary structure folding described for
yeast and human ESCRT factors (data not shown).
To determine whether the putative E. histolytica ESCRT
genes were expressed, we performed RT-PCR assays for the
16 most conserved genes. In basal culture conditions, 15
genes were transcribed, but the Ehvps22 transcript was not
detected in these experiments (see Figures 1(a) and 1(b)).
We also performed RT-PCR assays using RNA obtained
from trophozoites incubated with RBC for 5 minutes to
investigate whether erythrophagocytosis has an eﬀect on
ESCRT gene expression (see Figures 1(a) and 1(b)). In
these assays, we found that all genes were expressed during
erythrophagocytosis at similar levels as in basal conditions.
Again, we did not detect the Ehvps22 gene expression.
Interestingly, Ehvps23 and Ehadh112 were 2- and 3-fold
up-regulated, respectively. By densitometric analysis, the
band given by the ampliﬁed Eh25S rRNA product in both
conditions was taken as 100% and used to normalize ESCRT
genes data.
3.2. The Predicted EhVps4 Protein Conserves the Typical
Architecture of Vps4 Homologues. Since Vps4 orthologues
have been described as key molecules for the dissociation of
ESCRT, we ﬁrst focused on the characterization of the E. his-
tolytica EhVps4 protein. The predicted EhVps4 contains the
N-terminal MIT (microtubule interacting and transport),
AAA(ATPaseassociatedwithavarietyofactivities)andVps4
C-terminal domains (see Figure 2(a)) that are characteristic
and essential for Vps4 proteins biological functions [39, 40].
Phylogenetic trees revealed that EhVps4 is more related
to protozoan Vps4 than orthologous proteins from higher
eukaryotes (see Figure 2(b)). Interestingly, 3D modeling
of EhVps4, using the crystal structure of MIT and AAA
domains from yeast Vps4p and human Vps4B as templates
(see Figure 2(c)), showed that EhVps4 region spanning
the N-terminal MIT and AAA ATPase domains exhibited a
similar folding with the conserved Vps4 α-helices.
3.3. Expression and Immunodetection of EhVps4 Protein
in Trophozoites. We produced and puriﬁed the recombi-
nant EhVps4 protein as a GST-tagged fusion polypeptide
(rEhVps4-GST) in E. coli (see Figure 3(a), lanes 3, 4). By
Western blot assays using commercial anti-GST monoclonal
antibodies, we immunodetected the puriﬁed rEhVps4-GST
as a 72kDa protein in IPTG-induced bacteria (see Fig-
ure3(b),lane2)butnotinproteinextractsfromnoninduced
bacteria (see Figure 3(b), lane 1). The rEhVps4-GST was
digested with the PreScission Protease to obtain the rEhVps4Journal of Biomedicine and Biotechnology 5
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Figure 1: mRNA expression proﬁle of E. histolytica putative ESCRT machinery genes. (a) RT-PCR products obtained from 1μgo ft o t a lR N A
fromtrophozoitesgrowinginTYI-S-33medium(0minute)orafter5minutesoferythrophagocytosis.(b)DensitometricanalysisofRT-PCR
products in (a). Pixels corresponding to Eh25S rRNA ampliﬁed product were taken as 100% in each lane. Data represent the mean of three
independent experiments performed by duplicate for each gene. Asterisk, genes whose transcription is signiﬁcantly changed according to T
Student test.
untagged protein (47kDa) (see Figure 3(c),l a n e s2a n d3 ) ,
which was also puriﬁed (see Figure 3(c),l a n e4 )a n du s e dt o
generate rabbit polyclonal antibodies. Anti-rEhVps4 serum
recognized the untagged rEhVps4 protein, conﬁrming the
antibodies speciﬁcity (see Figure 3(d)). In addition, the same
antibodies detected a single 47kDa band in E. histolytica
p r o t e i ne x t r a c t s( s e eF i g u r e3(e), lane 1), which corresponds
to the expected molecular weight for the predicted EhVps4
polypeptide amino acid sequence. Antibodies did not detect
any other AAA ATPases predicted in the E. histolytica
genome [41]. Pre-immune serum, used as a control, did not
recognize any band in trophozoite extracts (see Figure 3(e),
lane 2). Through immunoﬂuorescence and laser confocal
microscopy assays, the speciﬁc rabbit polyclonal antibodies
revealed EhVps4 as abundant small dots dispersed in the
cytosol (see Figure 3(f)).
3.4. ATPase Activity Assays. To investigate whether the
recombinant protein exhibited ATPase activity we used the
rEhVps4 puriﬁed protein and a mutant version (EhVps4-
E211Q) in which we changed the E211 residue of the AAA
motif, essential for enzyme activity, by a Q residue (see Fig-
ure 4(a))[ 18, 42]. Reactions were carried out using the PiPer
Phosphate Assay Kit (Invitrogen) in the presence of 500μM
ATP. Inorganic phosphate (Pi) release was measured spec-
trophotometrically at A562. At zero time, absorbance values
of samples containing rEhVps4-GST, rEhVps4-E211Q-GST
and control rGST puriﬁed proteins (see Figure 4(b))w e r e
similar and they were taken as background. At 30 minutes,
A562 values increased to 0.115 ± 0.008 and 0.162 ± 0.022,
using 3.5μga n d5μg of rEhVps4-GST protein, respectively.
No signiﬁcant A562 increase was detected when we used
rEhVps4-E211Q-GST or rGST proteins at 30 minutes (see
Figure 4(c)). These results showed that rEhVps4-GST has
ATPase activity and that the AAA motif is essential for ATP
hydrolysis.
3.5. Generation of Trophozoites Overexpressing the EhVps4-
FLAG and Mutant EhVps4-E211Q-FLAG Proteins. To inves-
tigate the role of EhVps4 in E. histolytica, we generated
transfectant trophozoites that overexpress the EhVps4 and
the mutant EhVps4-E211Q FLAG-tagged proteins (see Fig-
ure 5(a)). Trophozoites transfected with pNEO vector were
used as control in these experiments. Viability of transfected
trophozoites was up to 90% as determined by trypan blue
exclusion assays.
RT-PCR assays, using speciﬁc primers for Ehvps4 gene,
showed that trophozoites transfected with pEhVps4 or
pEhVps4-E211Q plasmids expressed a higher amount of the
Ehvps4 transcript in comparison to pNEO transfected cells
(see Figure 5(b), upper panel, lanes 1, 2, and 3). As control,
we ampliﬁed the Eh25S rRNA transcript, which showed
minimal changes among the diﬀerent transfectants studied
(see Figure 5(b), lower panel).
By Western blot assays, using the anti-FLAG antibodies,
we detected the EhVps4-FLAG and EhVps4-E211Q-FLAGJournal of Biomedicine and Biotechnology 7
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Figure 2: Comparison of EhVps4 with other Vps4 proteins. (a) Schematic representation of Vps4 proteins from human, yeast and E.
histolytica. Conserved MIT, AAA, and Vps4 C-terminal (C) domains were predicted using PROSITE and Pfam programs. (b) Phylogenetic
relationships between EhVps4 and homologous proteins from other organisms. The phylogenetic tree of Vps4 homologues was created with
the MEGA 3.1 program using the Neighbor Joining algorithm based on ClustalW alignments of complete amino acids sequences. Numbers
on tree nodes represent the bootstrap proportions (%) of 1000 replications. The UniProt KnowledgeBase database accession number for
each protein is indicated before the organism. (c) Comparison of 3D structures of MIT and AAA domains from human (Hs), yeast (Sc)a n d
E. histolytica (Eh) Vps4 homologues. 3D modeling of EhVps4 MIT and AAA domains was obtained using crystal data from yeast Vps4p MIT
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Figure 3: Expression and immunodetection of EhVps4. (a) Expression and puriﬁcation of recombinant EhVps4-GST polypeptide. Proteins
were separated through 10% SDS-PAGE and gels were stained with Coomassie blue. Lane 1, molecular weight markers; lane 2, noninduced
bacteria extract; lane 3, IPTG-induced bacteria extract; lane 4, aﬃnity puriﬁed rEhVps4-GST from IPTG-induced bacteria extract. (b)
Immunodetection of rEhVps4-GST. Western blot assays were performed using noninduced bacteria extract (lane 1) and IPTG-induced
bacteria extract (lane 2), with anti-GST antibodies. (c) PreScission Protease digestion of rEhVps4-GST revealed by Coomassie blue stained
gels. Lane 1, molecular weight markers; lane 2, puriﬁed rEhVps4-GST protein; lane 3, rEhVps4-GST digested with PreScission Protease; lane
4,puriﬁedrEhVps4protein.(d)ImmunodetectionofpuriﬁedrEhVps4proteinbyWesternblotassaysusingspeciﬁcanti-rEhVps4antibodies
(lane 1). (e) Immunodetection of EhVps4 in total extracts of trophozoites using speciﬁc anti-rEhVps4 antibodies (lane 1) and preimmune
serum (lane 2). Proteins are indicated by arrowheads. (f) and (g) Cellular localization of EhVps4 in trophozoites. Trophozoites of clone A
were incubated with rabbit anti-rEhVps4 (f) or preimmune (g) serum, treated with FITC-labeled secondary antibodies, counterstained with
DAPI and analyzed through confocal laser microscopy. Left, cells observed in phase contrast; right, merge (trophozoites observed in the
green (FITC) and blue (DAPI) channels). Arrowheads, EhVps4 signal in small cytoplasmic dots.
proteins in pEhVps4 and pEhVps4-E211Q transfectant cells,
whereas no signal was detected in pNEO transfectantes, as
expected (see Figure 5(c), upper panel). However, speciﬁc
anti-rEhVps4 antibodies recognized endogenous EhVps4
pr oteininpNEOtransfectants(seeFigure5(c),middlepanel,
lane 1), meanwhile signal increased 2.8- and 9.2-fold in
pEhVps4 and pEhVps4-E211Q transfected cells, respectively
(see Figure 5(c), middle panel, lanes 2, and 3). Anti-
actin antibodies detected similar amounts of protein in the
diﬀerent transfectants (see Figure 5(c), lower panel). For
densitometric analysis, actin band was taken as 100% in
eachlaneandusedtonormalizeEhVps4,EhVps4-FLAG,and
EhVps4-E211Q-FLAG data (see Figure 5(d)).
3.6. Cellular Localization of EhVps4-FLAG and EhVps4-
E211Q-FLAG Proteins in Transfected Trophozoites. To inves-
tigate the cellular localization of exogenous wild type
EhVps4 and mutant EhVps4-E211Q FLAG-tagged proteins
in transfected trophozoites, we performed immunoﬂuores-
cence assays using anti-FLAG antibodies (see Figure 6).
In pEhVps4 transfected trophozoites, anti-FLAG antibodies
detected the overexpressed exogenous protein diﬀuse in the
cytoplasm and at the plasma membrane (see Figure 6(d)). In
contrast, in mutant pEhVps4-E211Q transfected cells, signal
wasnotobservedattheplasmamembrane,butitwaspresent
as cytoplasmic structures of varying sizes (see Figure 6(f)).
As expected, no signal was detected by anti-FLAG antibodies
in pNEO transfected cells (see Figure 6(b)). Control assays
without anti-FLAG primary antibodies did not show any
signal in transfected trophozoites (see Figure 6(h)).
3.7. Cytopathic Activity, Erythrophagocytosis and Liver
Abscesses Formation Are Impaired in Trophozoites Over-
expressing the Mutant EhVps4-E211Q-FLAG Protein. To
initiate the phenotypical characterization of trophozoites
transfected with pEhVps4 or pEhVps4-E211Q constructs,
we ﬁrst evaluated their cytopathic activity and rate of
erythrophagocytosis. Nontransfected clone A and pNEO
transfected cells were used as controls in these experiments.
After 1 hour interaction of MDCK cells with trophozoitesJournal of Biomedicine and Biotechnology 9
H Q
A
D A SE K
NN A V
SN A V
T G SL Q
SG S Q G
E Q
H PA QS
L T T ED V E K
S AK I W K N TC T A
Q
173
180
179
157
233
240
238
216
293
300
298
276
HsVps4A
HsVps4B
ScVps4p
EhVps4
HsVps4A
HsVps4B
ScVps4p
EhVps4
HsVps4A
HsVps4B
ScVps4p
EhVps4
AAA
R A N K V L D S S S S F T N A E T A V A K A L Y S K L S D E D I F K
N K V L D S S S S F T N A E T A V A K A L Y S K L S D E D I F K N E R A
N A E T A V A K A L Y S KQ K V L D S S S S F TD E D I F K N E R AL
A E T A V A K A L F S KS S F T S K V L R A L S D E D V F K N
R S G CEA E S E G Q M Q V F T K RT A GP I Y R K E F A S D L
R S G CEA E S EG Q M Q V F T K R T A GP I Y R K E F A S D L
E G R T GA E S ET K RG N M Q VT A G P I Y R R E F A S D L
CD G R S A E T EG N M Q V F T K RT A GI Y R K E F A T D L
E P L A R A A L R F M P S GA D T L NG S YD R V I IA S Q K R V P
E P L A R A L K F MT G G S Y A E T LA S Q K R V P D R V I I
D P L R A A F MI GP T LG S Y A S Q I K R I P D K V V V
D P L A R A MK G D T L Q P G S F L D K R V PQ A
V
I
V
V
I
I
I
I
V
V
L
S
P
P
P
P
I
I
I
I
A
A
A
I
I
I
I
R
R
R
R
Q
Q
Q
Q Y
I
I
I
I
R
R
R
R
M
M
M
S
S
S
S
R
R
R
R
L
L
L
I
T
S
S
A
A
L
L
M
W
W
W
W
Q
A
E
E
P
P
P
P
I
I
I
I
F
F
F
F
I
I
I
I
D
D
D
D
A
A
S
S
L
L
L
L
N
N
N
N
L
L
L
L
M
L
L
L
L
G
G
G
K
K
K
K
V
V
V
M
E
D
E
E
E
E
E
E
L
L
L
L
T
T
T
T
T
M
Q
S
S
S
S
I
V
V
K
K
A
E
E
E
E
E
G
G
G
G
R
R
Q
G
G
G
G
D
D
E
A
G
G
G
S
M
L
L
M
L
N
N
L
L
L
L
N
S
T
I
W
W
W
Y
D
D
E
E
V
H
K
K
K
K
N
N
N
R
R
K
I
S
S
S
S
G
G
G
G
F
Y
F
N
M
V
V
L
V
V
V
V
D
D
D
H
C
V
I
V
V
L
L
L
L
N
N L
F
F
F
Y
E
E
E
E
T
T
T
S
S
S
S
I
I
I
V
L
L
V
L
-
-
H
H
N
N
N
N
R
R
R
R
(a)
12 34
72
25
kDa
(b)
rEhVps4-GST rEhVps4-
E211Q-GST
rGST
3.5μg
5μg
0
0.05
0.1
0.15
0.2
A
b
s
o
r
b
a
n
c
e
(
5
6
2
n
m
)
(c)
Figure 4: Measurement of ATPase activity of recombinant EhVps4. (a) Multiple sequence alignment of Vps4 AAA domain from Homo
sapiens (HsVps4A and HsVps4B), S. cerevisiae (ScVps4p) and E. histolytica (EhVps4). Black boxes, identical amino acid (aa); grey boxes,
conserved substitutions; open boxes, diﬀerent aa. Numbers at the left are relative to the position of the initial methionine in each protein.
Arrowhead indicates the position of the conserved E residue. (b) Puriﬁcation of recombinant proteins. Proteins were expressed in E. coli,
puriﬁed through aﬃnity chromatography, separated through 10% SDS-PAGE and stained with Coomassie blue. Lane 1, rEhVps4-GST;
lane 2, rEhVps4-E211Q-GST; lane 3, rGST; lane 4, puriﬁed fraction from noninduced bacteria extract. (c) ATPase assay. ATPase activity of
rEhVps4-GST and rEhVps4-E211Q-GST was monitored as described in Section 2.7. rGST was included as control. Data are the mean of
three independent assays.
of clone A, pNEO or pEhVps4 transfected trophozoites,
monolayers presented in mean 86.8 ± 13.2% destruction.
Interestingly, pEhVps4-E211Q transfected cells were less
eﬃcient to destroy MDCK cell monolayers, since they only
produced 46.4 ± 6.4% cell destruction (see Figure 7(a)).
The rates of erythrophagocytosis of non-transfected
clone A, pNEO and pEhVps4 transfected cells were similar,
at each time tested. In contrast, pEhVps4-E211Q trans-
fected trophozoites showed 60, 55%, and 57% decrease
in erythrophagocytosis rate at 5, 10, and 15 minutes,
respectively, when compared with the mean rate from the
other trophozoites (see Figure 7(b)).
Then, we investigated the capacity of pEhVps4 and
pEhVps4-E211Q transfected trophozoites to induce hepatic
abscesses formation in hamsters. None of the six hamsters
that were infected with pEhVps4-E211Q transfected tropho-
zoites presented hepatic damage (see Figures 7(c)), whereas
the six animals infected with pNEO and pEhVps4 transfected
trophozoites developed extensive abscesses.
3.8. EhVps4 Was Detected around Ingested RBC. To deter-
mine the localization of EhVps4 in pEhVps4 transfected
trophozoites during erythrophagocytosis, we performed
immunoﬂuorescence assays with anti-rEhVps4 serum. Anti-
bodies detected EhVps4 as a signal surrounding ingested
erythrocytes, suggesting that this protein may be involved in
phagocytosis (see Figure 8).
4. Discussion
In E. histolytica trophozoites, phagocytosis, and vesicular
traﬃcking are important events for parasite nutrition and
destruction of target cells. As in other eukaryotes, the endo-
cytosis and phagocytosis pathways involve the formation of10 Journal of Biomedicine and Biotechnology
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Figure 5: Expression of exogenous EhVps4 in transfected trophozoites. (a) Schematic representation of pEhVps4-E211Q construct. Mutant
Ehvps4 gene was cloned into the KpnIa n dBamHI sites of pNEO vector, upstream the sequence coding for FLAG epitope. B, BamHI site;
K, KpnI site. (b) 2% agarose gel with RT-PCR assays products. An internal fragment of the Ehvps4 gene (upper panel) or the Eh25S rRNA
gene (bottom panel) was RT-PCR ampliﬁed using 1μg of total RNA from trophozoites of clone A transfected with pNEO (lane 1), pEhVps4
(lane 2) or pEhVps4-E211Q (lane 3) plasmid. (c) Western blot assays. Anti-FLAG (upper panel), anti-rEhVps4 (middle panel) and anti-actin
(lower panel) antibodies were used to analyze protein lysates (30 μg) from pNEO (lane 1), pEhVps4 (lane 2) and pEhVps4-E211Q (lane 3)
transfected cells. (d) Densitometric analysis of bands corresponding to actin and EhVps4 in (c). Pixels corresponding to actin control were
taken as 100% in each lane and used to normalize EhVps4 data.
endosomes, MVB and lysosomes [5, 43]. Indeed, MVBlike
structures have been detected in trophozoites [26, 27]a n d
within isolated phagosomes [24], but proteins participating
in their formation have not been identiﬁed.
Here, by mining the parasite genome sequence, we
demonstrated the presence of 20 genes that encode putative
ESCRT machinery components, which could participate in
endosomal transport and MVB formation in E. histolytica.
Most predicted proteins have the conserved functional
domains and share high similarity and phylogenetic rela-
tionship with homologous proteins from other eukaryotes,
strongly suggesting that they have similar functions. RT-
PCR assays evidenced that 15 out of 16 ESCRT components
tested are transcribed, which is consistent with the activity
of endosome formation and vesicle traﬃcking exhibited
by E. histolytica trophozoites (reviewed in [5, 43]). Except
for the Ehadh112 and Ehvps23 genes, transcript amount
was not signiﬁcantly modiﬁed after 5 minutes of RBC
interaction. Analysis of published E. histolytica microarrays
data conﬁrmed that most ESCRT genes are transcribed
without any signiﬁcant change under distinct experimental
conditions [44, 45]. However, these experiments were not
focused on phagocytosis. Additionally, in Dictyostelium
discoideum, microarrays assays evidenced that expression of
most genes involved in intracellular vesicle traﬃci sn o t
signiﬁcantly changed during phagocytosis [46]. In mouse
macrophages, phagocytosis causes cellular redistribution of
Hrs protein (the homologue of yeast Vps27p), but the
protein amount remains unchanged [47]. It is possible
that trophozoites could have enough ESCRT and associatedJournal of Biomedicine and Biotechnology 11
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antibodies, counterstained with DAPI and analyzed through confocal laser microscopy. pEhVps4-E211Q transfected trophozoites incubated
with FITC-labeled secondary antibodies were used as control ((g) and (h)). (a), (c), (e) and (g) Cells observed in phase contrast; (b), (d), (f)
and (h) Merge, trophozoites observed in the green (FITC) and blue (DAPI) channels. Arrowheads, EhVps4 signal in plasma membrane and
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Figure 7: Virulence assays of transfected trophozoites. (a) Cytopathic activity. The destruction of MDCK cells monolayers by clone A
trophozoites, pNEO,p EhVps4,o rp EhVps4-E211Q transfected cells was determined as described [32, 33]. (b) Erythrophagocytosis. Rate
of phagocytosis of clone A trophozoites, pEhVps4,p EhVps4-E211Q or pNEO transfected cells was evaluated at 5, 10, and 15 minutes [34].
Histograms show the mean count ± SD of three independent experiments by duplicate. (c) Hepatic damage in hamsters infected with
transfected trophozoites. Three groups of six hamsters were infected with pNEO,p EhVps4,o rp EhVps4-E211Q transfected trophozoites.
After 7 days, animals were sacriﬁced and liver damage was recorded. Pictures were taken from the liver side where the abscesses appeared to
be larger and are representative for each group. Upper panels, livers from hamsters infected with pNEO transfected trophozoites (control);
middle panels, livers from hamsters infected with pEhVps4 transfected trophozoites; lower panels, livers from hamsters infected with
pEhVps4-E211Q transfected trophozoites. 6/6, 6/6 and 0/6 denote number of infected animals/number of inoculated animals.
proteins to perform erythrophagocytosis, if, as we think,
these proteins are involved in phagocytosis in E. histolytica.
However, changes in the gene expression of E. histolytica
ESCRT members at shorter or larger times cannot be
discarded.
In yeast and mammal cells, Vps4 is a key component
for disassembly of ESCRT complexes from the endosomal
membrane at the MVB invagination pathway [42, 48, 49].
We focused on EhVps4 protein to investigate its role in
endocytosis, speciﬁcally in one of the “professional function”
ofE.histolyticatrophozoites:phagocytosis.Asinyeast,E.his-
tolytica has only one vps4 gene, while higher eukaryotes have
two vps4 genes [21, 50, 51]. By confocal microscopy, EhVps4
was immunodetected as abundant small dots dispersed in
the cytosol. In yeast, mammals, plants, and the protozoan
Leishmania major, similar structures have been identiﬁed as
MVB formed during endocytosis and vesicular traﬃcking
[22, 42, 51, 52].Journal of Biomedicine and Biotechnology 13
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Figure 8: Cellular localization of EhVps4 protein during erythrophagocytosis. Trophozoites transfected with pEhVps4 were incubated
with RBC, treated with diaminobenzidine, anti-rEhVps4 and FITC-labeled secondary antibodies, and analyzed through confocal laser
microscopy. (a) Cells observed in phase contrast. (b) Trophozoites observed in the green (FITC) channel and phase contrast. (c)
Magniﬁcation of diaminobenzidine stained RBC squared in (b). Arrowhead, EhVps4 signal around RBC. N, nuclei.
Yeast Vps4p protein exhibits ATPase activity, which
dependsontheE233residuepresentwithintheAAAdomain
[18, 42]. In this work, we showed that EhVps4 is an ATPase,
which conserves the characteristic domains and folding
of Vps4 homologues. This activity depends on the AAA
domain since the mutant rEhVps4-E211Q-GST, in which
E211 amino acid residue was substituted by Q residue, did
not exhibit detectable ATP hydrolysis, as reported in yeast
[18, 42].
We further investigated the biological relevance of
EhVps4 by generating trophozoites that overexpress wild
type EhVps4-FLAG and mutant EhVps4-E211Q-FLAG pro-
tein. As the endogenous protein, exogenous EhVps4-FLAG
was located in abundant punctuate structures in the cytosol
as reported in other organisms [42, 50, 52, 53]. However,
overexpressed EhVps4-FLAG was also detected at plasma
membrane. In transfected mammal cells that overexpress
Sendai virus protein C and wild type Vps4, ALIX/AIP1
proteins are recruited at the plasma membrane to facilitate
the budding of virus-like particles [54]. EhADH112, the E.
histolytica homologue of ALIX, has been detected at the
plasma membrane [55]. Experiments currently in progress
will help us to deﬁne the role of Vps4 at the membrane of
trophozoites.
Erythrophagocytosis and cytopathic activities were not
improved in trophozoites overexpressing wild type EhVps4-
FLAG, probably because other ESCRT proteins are limiting
factorsforcelldestructionandRBCintake[42,52,56].How-
ever,thedominantnegativeeﬀectofmutantEhVps4-E211Q-
FLAG protein in MDCK cells destruction, the rate of RBC
intake, and liver abscesses formation in hamsters, suggest a
role for EhVps4 in E. histolytica virulence properties. The
localization of EhVps4-FLAG protein around ingested RBC
strengthens this hypothesis.
In conclusion, we showed that E. histolytica has an
ESCRT machinery, which is transcribed in trophozoites. Par-
ticularly, we presented evidence that the conserved EhVps4
is an ATPase that could participate in cytopathic activity and
erythrophagocytosis,aswellasinhepaticdamageinhamster.
Work currently in progress is focusing on the identiﬁcation
of cytoplasmic structures containing EhVps4, as well as
its interaction with other components of the E. histolytica
ESCRT machinery.
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